Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Excelerate Energy
EE
$764M
| $1.41M | ﹤0.01% |
69,200
-5,000
| -7% | -$102K |
|
2227
ProShares UltraPro Short Dow 30
SDOW
$171M
| $1.4M | ﹤0.01% |
+14,675
| New | +$1.4M |
|
2228
Zynex
ZYXI
$44.8M
| $1.4M | ﹤0.01% |
146,135
+44,600
| +44% | +$428K |
|
2229
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$1.73B
| $1.4M | ﹤0.01% |
69,400
-20,457
| -23% | -$412K |
|
2230
Luminar Technologies
LAZR
$146M
| $1.4M | ﹤0.01% |
13,550
-219,670
| -94% | -$22.7M |
|
|
WHWK
2231
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$87.7M
| $1.4M | ﹤0.01% |
204,122
-121,602
| -37% | -$832K |
|
|
SILV
2232
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $1.4M | ﹤0.01% |
+238,141
| New | +$1.4M |
|
|
EVA
2233
DELISTED
Enviva Inc.
EVA
| $1.4M | ﹤0.01% |
128,700
-17,300
| -12% | -$188K |
|
2234
Curis
CRIS
$21.2M
| $1.4M | ﹤0.01% |
84,062
+2,692
| +3% | +$44.7K |
|
2235
iShares Core Moderate Allocation ETF
AOM
$1.62B
| $1.39M | ﹤0.01% |
34,500
-5,100
| -13% | -$206K |
|
|
ADAP
2236
Adaptimmune Therapeutics
ADAP
$17.7M
| $1.39M | ﹤0.01% |
1,506,375
+1,323,675
| +725% | +$1.22M |
|
|
STKL
2237
SunOpta
STKL
$758M
| $1.39M | ﹤0.01% |
208,138
+26,200
| +14% | +$175K |
|
2238
Citizens & Northern Corp
CZNC
$311M
| $1.39M | ﹤0.01% |
72,041
+1,100
| +2% | +$21.2K |
|
2239
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$14.5B
| $1.39M | ﹤0.01% |
+15,900
| New | +$1.39M |
|
2240
iShares Global Clean Energy ETF
ICLN
$1.6B
| $1.39M | ﹤0.01% |
+75,304
| New | +$1.39M |
|
2241
Vanguard S&P 500 Value ETF
VOOV
$5.71B
| $1.39M | ﹤0.01% |
+8,900
| New | +$1.39M |
|
2242
iShare MSCI Eurozone ETF
EZU
$8.05B
| $1.38M | ﹤0.01% |
+30,200
| New | +$1.38M |
|
2243
Worthington Enterprises
WOR
$3.18B
| $1.38M | ﹤0.01% |
+32,278
| New | +$1.38M |
|
2244
SITE Centers
SITC
$458M
| $1.38M | ﹤0.01% |
133,943
-256,422
| -66% | -$2.64M |
|
2245
Corporacion America
CAAP
$3.14B
| $1.38M | ﹤0.01% |
118,961
+38,861
| +49% | +$450K |
|
2246
Invesco Aerospace & Defense ETF
PPA
$6.33B
| $1.38M | ﹤0.01% |
16,300
+9,600
| +143% | +$811K |
|
2247
ALX Oncology
ALXO
$56.2M
| $1.37M | ﹤0.01% |
182,800
+55,981
| +44% | +$420K |
|
2248
8x8 Inc
EGHT
$290M
| $1.37M | ﹤0.01% |
323,788
-130,442
| -29% | -$552K |
|
2249
Sinclair Inc
SBGI
$972M
| $1.37M | ﹤0.01% |
99,155
-318,816
| -76% | -$4.41M |
|
2250
Structure Therapeutics
GPCR
$1.16B
| $1.37M | ﹤0.01% |
+32,900
| New | +$1.37M |
|